Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 11BETA,17,21-TRIHYDROXY-PREGN-4-ENE-3,20-DIONE METHYL ESTER 3-[(NITROOXY) METHYL]-BENZOIC ACID
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

571186-50-0

571186-50-0 structure

Name: NCX1022
Chemical Name: 11beta,17,21-trihydroxy-pregn-4-ene-3,20-dione methyl ester 3-[(nitrooxy) methyl]-benzoic acid
CAS Number: 571186-50-0
Molecular Formula: C₂₉H₃₅NO₉
Molecular Weight: 541.58900
Catalog: Research Areas Inflammation/Immunology
Create Date: 2017-05-14 01:46:14
Modify Date: 2024-01-15 11:13:49
NCX1022 is an NO-releasing derivative of Hydrocortisone, which is the most widely used anti-inflammatory drug for the treatment of skin inflammation.

Name	11beta,17,21-trihydroxy-pregn-4-ene-3,20-dione methyl ester 3-[(nitrooxy) methyl]-benzoic acid
Synonyms	no-hydrocortisone ncx 1022 NCX1022

Description	NCX1022 is an NO-releasing derivative of Hydrocortisone, which is the most widely used anti-inflammatory drug for the treatment of skin inflammation.
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Inflammation/Immunology
In Vivo	Topical pre- and post-treatment with NCX1022 (3 nmol) in C57BL6 mice not only reduces ear oedema formation in a dose-dependent manner, but also is significantly more effective than the parent compound during the initial stages of inflammation (from 1 to 5 h). NCX1022, but not Hydrocortisone, significantly inhibits granulocyte recruitment (tissue myeloperoxidase activity). Histological samples of mouse ears treated with NCX1022 show significant reduction in both the number of infiltrated cells and disruption of the tissue architecture compared to Hydrocortisone-treated tissues. Post-treatment with Hydrocortisone does not modify the increased granulocyte infiltration induced by benzalkonium application, but NCX1022 reduces by 63% the myeloperoxidase (MPO) activity, producing a maximum effect at the dose of 3 nmol per ear. NCX1022 is significantly more potent than Hydrocortisone in reducing contact dermatitis-induced leukocyte adhesion, particularly at the early time points (e.g., 30-60 min after dermatitis induction)[1].
References	[1]. Hyun E, et al. Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis. Br J Pharmacol. 2004 Nov;143(5):618-25.